Urinary tract infections (UTI) are among the most common infectious diseases of humans and are the most common nosocomial infection in the developed world. It is estimated that 40-50% of women and 5% of men will develop a UTI in their lifetime, and UTI accounts for more than 1 million hospitalizations and $1.6 billion in medical expenses each year in the USA. Uropathogenic Escherichia coli (UPEC) is the primary cause of UTI. This review presents an overview of recent discoveries related to the primary virulence factors of UPEC and major innate immune responses to infection of the lower urinary tract. New and emerging themes in UPEC research are discussed in the context of the interface between host and pathogen. 
Introduction
Urinary tract infections (UTI) are one of the most common bacterial infections of humans and are a major cause of morbidity. UTI usually starts as a bladder infection (cystitis), but can develop to acute kidney infection (pyelonephritis), ultimately resulting in scarring and renal failure. UTI is caused by a range of pathogens, with uropathogenic Escherichia coli (UPEC) being the most common etiological agent. This review will focus on UPEC, discussing recent advances in our knowledge of its virulence factors and innate immune responses to acute bladder infection.
UPEC express multiple virulence factors that promote UTI
UPEC cause more than 80% of all UTI. UPEC strains possess an arsenal of virulence factors that contribute to their ability to cause disease, including fimbrial adhesins, toxins, flagella, autotransporter proteins and iron-acquisition systems [1] . UPEC fitness in the nutritionally poor urinary tract is also aided by the utilization of short peptides and amino acids as a carbon source during infection [2] as well as the presence of type II toxinantitoxin systems [3] .
UPEC adherence to the urinary tract epithelium is primarily mediated by fimbriae assembled by the chaperone-usher pathway [4] (Box 1). Type 1 fimbriae, one of the bestcharacterized UPEC chaperone-usher fimbriae, bind to α-D-mannosylated proteins such as uroplakins that are abundant in the bladder via the tip-located FimH adhesin. Type 1 fimbriae enhance colonization and activation of host innate immune pathways in the murine UTI model, and promote biofilm formation and host cell invasion [1] . FimHmediated binding to target receptors is enhanced through the formation of catch bonds, mechanical forces that contribute to FimH-receptor complex interactions [5] . Recent work 4 has also shown that FimH is recognized by host pattern recognition receptors (PRRs), thus leading to potent induction of innate antimicrobial responses [6] . Additional UPEC surface components that contribute to colonization of the urinary tract include established factors such as other fimbriae (e.g. P, F1C, S and Afa) [7] and more recently identified factors such as curli [8] , autotransporter proteins (e.g. Ag43, UpaH) [9,10], TosA [11] and flagella [12] .
UPEC secrete a number of toxins that damage or kill host epithelial cells. One of the most common UPEC toxins, α-hemolysin, mediates host cell lysis, thus promoting the release of nutrients such as iron that can be utilized by UPEC for growth and/or survival. Sublytic concentrations of α-hemolysin also contribute to virulence by enabling UPEC to modulate epithelial cell functions as will be discussed later [13] . Another toxin, cytotoxic necrotizing factor 1 (CNF1) is a Rho GTPase that promotes invasion of UPEC into host cells [14] .
Recent data suggest that UPEC CNF1 and α-hemolysin may contribute to the signs and symptoms of cystitis (along with LPS as discussed further below) [15] . In the zebrafish model, α-hemolysin and CNF1 function primarily in the neutralization of phagocytes [16] .
Iron is essential for bacterial growth and is limited in the urinary tract. Four Autophagy has emerged as an important mechanism in bacterial pathogenesis, and recent data suggests that this process is involved in innate defense against UPEC. Wang et al.
demonstrated a pro-pathogen role for the autophagy protein Atg16L1; deficiency in this factor conferred protection against infection [67] . Utilization of autophagy pathways by UPEC may impede the release of inflammatory cytokines such as IL-1 [68] . Two other separate studies on attenuation of innate responses by UPEC in the context of dampening innate responses offer alternative avenues for further investigation; firstly, the discovery that cyclooxygenase-2 is regulated by UPEC in urothelial cells [69] , and secondly, the finding that indoleamine 2,3-dioxygenase is induced by UPEC, which attenuates innate responses to epithelial infection [70] . Jointly, these data suggest a potential link between cyclooxygenase-2 and indoleamine 2,3-dioxygenase in UPEC mediated UTI, as reviewed elsewhere in the context of non-infectious diseases [71] .
Challenges, Opportunities and Future Research Directions
As with many pathogens, UPEC employs multiple strategies to evade and manipulate host barrier defence and innate immune responses. Our increased understanding of these pathogen-host interactions has uncovered novel approaches that could be used to combat UPEC mediated UTI, such as strategies aimed at selectively boosting the production or function of molecules like IL-10, IL-17, cathelicidin and serum amyloid A. Novel therapeutics using pathogen-derived molecules that directly impact innate immune responses and manipulate host response pathways also seem plausible. These areas of investigation should be considered in view of the genotypic and phenotypic diversity of UPEC clonal groups, and the wide spectrum of UTI pathologies associated with different strains. While research has focused on prototype UPEC strains such as CFT073 and UTI89, future research also needs to study emerging strains. In particular, the pathogenesis mechanisms employed by multidrug resistant UPEC strains such as the globally disseminated E. coli ST131 clone should be addressed. 
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BOX 1
Adherence to host cells, a critical first step in UPEC infection, is mediated by fimbriae.
• Chaperone-Usher (CU) fimbriae are encoded by a cluster of genes under the control of the same promoter (operon). CU fimbrial operons typically consist of a gene set encoding an outer membrane usher and a periplasmic chaperone, flanked by one or more genes encoding structural subunits.
• Many UPEC strains contain >10 CU fimbrial operons. These are either located on the chromosome backbone or on mobile genetic elements, such as pathogenicity islands and plasmids.
• Expression of some CU fimbriae in UPEC is phase variable, resulting in heterogeneous bacterial populations with respect to adhesin production.
• CU fimbriae are hierarchically displayed at the bacterial cell surface via regulatory cross-talk. This aids the temporal and spatial colonisation of distinct niches during infection. For example, expression of P fimbriae in UPEC turns off type 1 fimbriae (negative cross-talk), while it sequentially turns on other P-related fimbrial operons (positive cross-talk) [72] .
• Regulatory cross-talk also takes place between CU fimbriae and other surface organelles of UPEC, such as flagella, capsule and the autotransporter protein antigen 43.
